SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001811764-21-000038
Filing Date
2021-12-10
Accepted
2021-12-10 08:24:28
Documents
19

Document Format Files

Seq Description Document Type Size
1 424B3 a424b3-8xkcombinedxdecembe.htm 424B3 34499
2 EX-10.1 exhibit101.htm EX-10.1 15383
3 EX-10.2 exhibit102.htm EX-10.2 13559
4 EX-10.3 exhibit103.htm EX-10.3 16077
5 GRAPHIC exhibit101001.jpg GRAPHIC 209724
6 GRAPHIC exhibit101002.jpg GRAPHIC 310490
7 GRAPHIC exhibit101003.jpg GRAPHIC 267481
8 GRAPHIC exhibit101004.jpg GRAPHIC 278695
9 GRAPHIC exhibit101005.jpg GRAPHIC 56564
10 GRAPHIC exhibit102001.jpg GRAPHIC 193489
11 GRAPHIC exhibit102002.jpg GRAPHIC 298752
12 GRAPHIC exhibit102003.jpg GRAPHIC 280310
13 GRAPHIC exhibit102004.jpg GRAPHIC 214868
14 GRAPHIC exhibit103001.jpg GRAPHIC 191488
15 GRAPHIC exhibit103002.jpg GRAPHIC 294862
16 GRAPHIC exhibit103003.jpg GRAPHIC 267236
17 GRAPHIC exhibit103004.jpg GRAPHIC 294381
18 GRAPHIC exhibit103005.jpg GRAPHIC 112680
19 image_0a.jpg GRAPHIC 7287
  Complete submission text file 0001811764-21-000038.txt   4596998
Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268
Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (647) 401-2182
POINT Biopharma Global Inc. (Filer) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-258325 | Film No.: 211483718
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences